Boyer, A. P., Collier, T. S., Vidavsky, I., & Bose, R. (2013). Quantitative Proteomics with siRNA Screening Identifies Novel Mechanisms of Trastuzumab Resistance in HER2 Amplified Breast Cancers. The American Society for Biochemistry and Molecular Biology.
Citação norma ChicagoBoyer, Alaina P., Timothy S. Collier, Ilan Vidavsky, and Ron Bose. Quantitative Proteomics With SiRNA Screening Identifies Novel Mechanisms of Trastuzumab Resistance in HER2 Amplified Breast Cancers. The American Society for Biochemistry and Molecular Biology, 2013.
MLA citiranjeBoyer, Alaina P., Timothy S. Collier, Ilan Vidavsky, and Ron Bose. Quantitative Proteomics With SiRNA Screening Identifies Novel Mechanisms of Trastuzumab Resistance in HER2 Amplified Breast Cancers. The American Society for Biochemistry and Molecular Biology, 2013.